COMMUNICATION LEUCINE IN AGE-ASSOCIATED SARCOPENIA

A progressive loss of muscle mass has been well described in both humans and rodents during ageing. This loss of proteins results from an imbalance between protein synthesis and degradation rates. Although some authors have shown a decrease of myofibrillar protein synthesis rates in human volunteers, this imbalance is not clearly apparent when basal rates of protein turnover are measured. A decrease in muscle protein synthesis stimulation has nevertheless been detected in ageing rats during the postprandial per-iod, suggesting that the ‘meal signal ’ is altered during ageing. Many results now suggest that aged muscle is less sensitive to the stimulatory effect of amino acids at physiological concentrations, but is still able to respond if the increase in aminoacidaemia is sufficiently large. Indeed, amino acids play an important role in regulating muscle protein turnover both in vitro and in vivo. Of amino acids, leucine seems to play the key role in regulating the metabolic function. It inhibits proteolysis and stimulates muscle pro-tein synthesis independently of insulin. Leucine has been shown to act as a mediator, by modulating spe-cifically the activities of intracellular kinases linked to the translation of proteins such as phosphatidy-linositol 3 _ kinase and mammalian target of rapamycin – 70 kDa ribosomal protein S6 (p70S6K) kinases. We recently demonstrated in vitro that protein synthesis in ageing rat muscles becomes resistant to the stimulatory effect of leucine in its physiological concentration range. Protein synthesis was however sti